Clinical Trial Site is a clinical research site located in Cleveland, Ohio, United States 44195.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Clinical Trial Site has participated in 18 clinical trials with 10 currently active.
Therapeutic areas: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, ANCA-Associated Vasculitis, Primary Hyperoxaluria Type 1 (PH1).
Sponsors: Alnylam Pharmaceuticals, Amgen, Priovant Therapeutics, Inc..
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Clinical Trial Site has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Clinical Trial Site has 18 clinical trials on record, with 10 currently active. Their work covers Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, ANCA-Associated Vasculitis, Primary Hyperoxaluria Type 1 (PH1).
Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.